|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 4807 | Drugs / Medical | 05/16/2006
Bristol-Myers Squibb confirms that the antibiotic Tequin, which has been linked to serious blood sugar complications, is being taken off the market. The company will stop making and selling the drug and return its rights to Kyorin Pharmaceutical Company in Japan.
Company spokesman Eric Miller said the company decided to remove the antibiotic from the market after a commercial evaluation of the product as well as changes in the company's focus. Tequin, approved for sale in 1999, has faced questions about its effects on blood sugar, being associated with both high and low blood sugar in some patients. In February, the Food and Drug Administration required increased warnings on the drug's label. The manufacturer has warned that it should not be used by diabetics and said the elderly and those with kidney disease are more likely to have problems. Public-interest group Public Citizen petitioned the FDA to ban the antibiotic. In its petition, Public Citizen said there have been 388 patients with blood-sugar irregularities associated with the drug, including 20 deaths and 159 hospitalizations since Jan. 1, 2000. Public Citizen urged the FDA to order a recall of the drug. "This drug carries unique risk but has no unique benefits and therefore should not be on the market," said the director of Public Citizen's Health Research Group. Tequin is prescribed for chronic bronchitis, sinusitis, pneumonia, urinary tract and other infections. Have you or a loved one experienced blood sugar complications during or shortly after use of Tequin? If so, please click on the above link to have one of our attorneys contact you. Register your Bristol Myers Squibb ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Bristol Myers Squibb, or click the red "submit" button on this page, and a lawyer will review your Bristol Myers Squibb complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Several class actions have been filed against biotechnology company Biopure Corporation (Nasdaq:BPUR) and certain of its officers and directors by stockholders who purchased the company's common stock between March 17, 2003, and December 24, 2003. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations regarding Biopure’s blood replacement product to the market over this time period, thereby artificially inflating the price of the company's securities. Prescription expiration dates should be obeyed to assure that your medication works effectively. A class action filed against Walgreen Company on behalf of prescription purchasers who claim that Walgreen’s policy of placing its own expiration dates of one year from the date of purchase on prescriptions dispensed wrongly denied them the full and safe use of the medications. The Tennessee Medical Association and Blue Cross Blue Shield of Tennessee have resolved a five-year class action lawsuit over billing and other business practices. The ban on importation of vital prescription drugs from Canada is placing many seniors in dire financial straits only to ensure that corporate profit margins maintain their exorbitant levels. A class action has been filed against the U.S. Department of Health and Human Services on behalf of prescription drug purchasers, who allege that the federal prohibition on the importation of prescription drugs from Canada by anyone other than the manufacturer violates their constitutional rights on numerous counts. Kahn Gauthier Swick is investigating possible legal actions against the makers of Paxil, Prozac, Zoloft, Lexapro, Celexa, Effexor, and Wellbutrin, respectively, to recover for suicides or homicides--some completed, some only attempted--by patients in the first few days or weeks after they were prescribed one of these drugs. Lipitor is the #1 prescribed cholesterol-lowering drug in the United States. A nationwide class action has been filed against pharmaceutical distributors Albers Medical, Inc., and Med-Pro, Inc. on behalf of consumers who allege that the companies repackaged and distributed counterfeit Lipitor and possibly other drugs as well. The action alleges that the companies violated the federal Racketeer Influenced Corrupt Organizations Act and the Missouri Merchandising Practices Act in distributing the counterfeit drugs. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
